Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available vitamin could become a powerful new treatment.
Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers have uncovered a key genetic factor that wo… [+2712 chars]
